News

iSTAR Medical completes enrolment of first-in-human MIGS trial

Novel MINIject device made from STAR® material successfully implanted in 25 patients WAVRE, Belgium — 17 October 2017: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the completion of enrolment in their first-in-human (FIH) micro-invasive glaucoma surgery (MIGS) trial for the MINIjectTM device.

iSTAR Medical Strengthens Board with Two Senior Appointments

Martin Wax, M.D. and Marc Nolet de Brauwere appointed to Board of Directors WAVRE, Belgium — 28 June 2016: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the appointment of Martin Wax, M.D. and Marc Nolet de Brauwere to the Board of Directors. Dr […]

iSTAR Medical Secures €10 Million Financing

WAVRE, Belgium — 12 April 2016: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the closing of a €10 million Series B equity financing. Existing shareholders including Capricorn Venture Partners and Walloon Region Investment Fund (SRIW) contributed to the round, which was joined by […]

iSTAR Medical Appoints Medical Device Executive Michel Lussier as Chairman of its Board of Directors

ISNES, Belgium, April 27, 2015 /PRNewswire/ — iSTAR Medical SA, a Belgium ophthalmic device company, announced today the appointment of Michel Lussier as Chairman of the company’s Board of Directors.

iStar Medical Announces First Patient Implanted with STARflo™ Glaucoma Drainage Device in European Clinical Trial

Isnes, Belgium (Oct 30, 2014) – iSTAR Medical SA, a privately held ophthalmic device company, announced today that the first patient in its European multi-center clinical trial has been successfully implanted with the STARflo™ glaucoma drainage device.